PilaSite sustained release eyedrops: Began a second Phase III trial

InSite Vision Inc. (INSV), Alameda, Calif. Product: PilaSite sustained release eyedrops containing 2 percent pilocarpine Indication: Glaucoma Status: Began a second Phase III trial in 200 patients wit...